These results support the rationale to offer to Ph+ ALL elderly patients or adult patients not eligible for intensive chemotherapy and allo-SCT, a line treatment without chemotherapy, by using a TKI as debulking induction treatment and subsequently by adding a potentially synergic leukemia-specific immune approach such as a p190-derived peptide vaccine. This evidence concerns the gene CNTNAP1 and leukemia.